The future for CLL?: In the last few years, we... - CLL Support

CLL Support

23,088 members39,645 posts

The future for CLL?

AussieNeil profile image
AussieNeilPartnerAdministrator
2 Replies

In the last few years, we've seen some great advances in the efficacy of new treatments for CLL, with very encouraging progress towards a cure. There has even been talk that we may have achieved the breakthrough that Imatinib (perhaps better know as Gleevec) was for a sister leukaemia to CLL - CML or Chronic Myelogenous Leukaemia, with some of the new maintenance drugs such as Ibrutinib (Imbruvica). In some countries, we can actually access the new drugs! Unfortunately, talk of the new CLL drugs being our version of Imatinib is definitely premature, as a review of the Wikipedia article will quickly show:

en.wikipedia.org/wiki/Imatinib

Note particularly: "Because the BCR-Abl tyrosine kinase enzyme exists only in cancer cells and not in healthy cells, imatinib works as a form of targeted therapy—only cancer cells are killed through the drug's action."

A big problem of course is that Imatinib, Ibrutinib and other small molecule drugs are maintenance drugs - you need to remain on them indefinitely and put up with the side effects, not to mention the crippling cost of around US$100,000 per year.

So here's a glimpse into the future that we'd really like to see:

"Results from a small study suggest that induction treatment with interferon alpha 2a (IFN) along with imatinib, followed by temporary IFN maintenance therapy, could help patients with chronic myeloid leukemia (CML) discontinue imatinib treatment."

cancernetwork.com/chronic-m...

Bear in mind that Imatinib/Gleevec was approved way back in 2001, but it is encouraging that CLL researchers are beginning to look at how these new drugs can be used either sequentially or in concert with other, established CLL treatments to achieve that dream cure.

Meanwhile it is encouraging that the old gold standard of FCR may be curing some patients that have the right markers; a 6 month course and no more CLL treatment for the rest of your life!

Neil

Photo: A young Australian magpie - easily identified by the light grey downy breast feathers. Magpies have a melodious call and are great mimics, but they also have a penchant for swooping on you during nesting season. On several occasions while cycling, I've been glad that helmet wearing is compulsory in Australia, having had magpies swooping from behind and 'beaking' my helmet. There are even websites warning cyclists where to be on the lookout for swooping magpies. Wearing a hat with sunglasses or painted eyes on the back works reasonably well as a deterrent as they rarely attack from the front, but last year I stood my ground and captured on camera (using burst mode) a magpie swooping directly towards me before veering away at the last moment.

Written by
AussieNeil profile image
AussieNeil
Partner
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Justasheet1 profile image
Justasheet1

I pray every day for this.

Jeff

Ernest2 profile image
Ernest2

Many thanks for that Neil.

Will be interesting to see the phase 3 trial results in Germany when that comes along.

I'm more than happy to see progress in other leukaemias as I'm sure it also promotes development elsewhere.

Ernest.

Not what you're looking for?

You may also like...

It's Official! Curing Patients Is Bad for Business! Milton Packer describes the end result of profit-dominated drug development

Sobering reading from Milton Packer in Medscape Today "Pharmaceutical companies are developing...

Does Vitamin C really help with CLL?

Has anyone else seen the report in the New Scientist of 25.08.17 which reported on trials involving...

Trabectedin Targets Leukemic Cells and Restores Immune Cell Function in Models of Chronic Lymphocytic Leukemia

The marine-derived compound trabectedin depletes both human primary leukemic cells and...

Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell CLL

Chronic Lymphocytic Leukaemia (CLL) is associated with immune suppression and susceptibility to...

Leukaemia Care Updated Patient Information - Richter's Syndrome in Chronic Lymphocytic Leukaemia

Leukaemia Care is a UK charity so the support information is UK based. However the information...